Potentiating effect of eszopiclone on GABAA receptor-mediated responses in pedunculopontine neurons

Sleep

Volumn 32, Issue 7, 2009, Pages 879-887

  Ye, Meijun ^a   Garcia Rill, Edgar ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

GABAA receptor; Pedunculopontine nucleus; Sleep; Waking

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 4 AMINOBUTYRIC ACID A RECEPTOR; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ARECAIDINE; ESZOPICLONE; TETRODOTOXIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; GABAERGIC SYSTEM; INHIBITORY POSTSYNAPTIC POTENTIAL; NEUROMODULATION; NONHUMAN; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PRIORITY JOURNAL; RAT;

EID: 67651155936     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.1093/sleep/32.7.879     Document Type: Article

References (33)

1. Datta S. Activation of pedunculopontine tegmental PKA prevents GABAB receptor activation-mediated rapid eye movement sleep suppression in the freely moving rat. J Neurophysiol 2007;97:3841-50.
2. Ulloor J, Mavanji V, Saha S, Siwek DF, Datta S. Spontaneous REM sleep is modulated by the activation of the pedunculopontine tegmental GABAB receptors in the freely moving rat. J Neurophysiol 2004;91:1822-31.
3. Arnaud C, Gauthier P, Gottesmann C. Study of a GABAC receptor antagonist on sleep-waking behavior in rats. Psychopharmacol 2001;154:415-9.
4. Goa KL, Heel RC. Zopiclone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as a hypnotic. Drugs 1986;32:48-65.
5. Hoehns JD, Perry PJ. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia. Clin Pharm 1993;12:814-28.
6. Hair PI, McCormack PL, Curran MP. Eszopiclone: a review of its use in the treatment of insomnia. Drugs 2008;68:1415-34.
7. Morin AK. Strategies for treating chronic insomnia. Amer J Manag Care 2006;12:230-45.
8. Blanchard JC, Boileau A, Julou L. Brain receptor and zopiclone. Int Pharmacopsychiat 1982;17:59-69.
9. Doble A, Canton T, Malgoris C, et al. The mechanism of action of zopiclone. Eur Psychiat 1995;10:117-28.
10. Davies MJ, Newell G, Derry JM, Martin IL, Dunn SMJ. Characterization of the interaction of zopiclone with γ-aminobutyric acid type A receptors. Mol Pharmacol 2001;58:756-62.
11. Seighart W. Sperk G. Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem 2002;2:795-816.
12. Gauthier P, Arnaud C, Stutzman JM, Gottesman C. Influence of zopiclone, a new generation hypnotic, on the intermediate stage and paradoxical sleep in the rat. Psychopharmacology 1997;130:139-43.
13. Gottesman C, Gandolfo G, Arnaud C, Gauthier P. The intermediate stage and paradoxical sleep in the rat: influence of three generations of hypnotics. Eur J Neurosci 1998;10:409-14.
14. Yoshimoto M, Higuchi H, Kamata M, Yoshida K, Shimizu T, Hishikawa Y. The effects of benzodiazepine (triazolam), cyclopyrrolone (zopiclone) and imidazopyridine (zolpidem) hypnotics on the frequency of hippocampal theta activity and sleep structure in rats. Eur Psychopharmacol 1999;9:29-35.
15. Xi M, Chase MH. Effects of eszopiclone and zolpidem on sleep and waking states in the adult guinea pig. Sleep 2008;31:1043-51.
16. Tobler I, Borbely AA. Sleep EEG in the rat as a function of prior waking. Electroenceph Clin Neurophysiol 1986;64:74-6.
17. Steriade M, McCarley RW. Brainstem control of wakefulness and sleep. New York: Plenum Press, 1990.
18. Bay KD, Beck P, Skinner RD, Garcia-Rill E. GABAergic modulation of developing pedunculopontine nucleus (PPN). NeuroReport 2007;18:249-53.
19. Ye M, Hayar A, Garcia-Rill E. Electrical coupling in pedunculopontine nucleus (PPN) neurons. Neurosci Abst 2007;30:581.10.
20. Garcia-Rill E, Heister DS, Ye M, Charlesworth A, Hayar A. Electrical coupling: novel mechanism for sleep-wake control. Sleep 2007;30:1405-14.
21. Farrant M, Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci 2005;6:215-29.
22. Leonard CS, Llinas R. Electrophysiology of mammalian pedunculopontine and laterodorsal tegmental neurons in vitro: implications for the control of REM sleep. In: Steriade M, Biesold D eds. Brain cholinergic systems. Oxford: Oxford Science, 1990:205-23.
23. Kamondi A, Williams J, Hutcheon B, Reiner P. Membrane properties of mesopontine cholinergic neurons studied with the wholecell patch-clamp technique: implications for behavioral state control. J. Neurophysiol 1992;68:1359-72.
24. Takakusaki K, Kitai ST. Ionic mechanisms involved in the spontaneous firing of tegmental pedunculopontine nucleus neurons of the rat. Neuroscience 1997;78:771-94.
25. Takakusaki K, Shiroyama T, Yamamoto T, Kitai ST. Cholinergic and noncholinergic tegmental pedunculopontine projection neurons in rats revealed by intracellular labeling. J Comp Neurol 1996;371:345-61.
26. Debanne D, Guerineau NC, Gahwiler BH, Thompson SM. Paired-pulse facilitation and depression at unitary synapses in rat hippocampus: quantal fluctuation affects subsequent release. J Physiol 1996;491:163-76.
27. Cherubini E, Gaiarsa JL, Ben-Ari Y. GABA: an excitatory transmitter in early postnatal life. Trends Neurosci 1991;14:515-9.
28. Brickley SG, Revilla V, Cull-Candy SG, Wisden W, Farrant M. Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature 2001;409:88-92.
29. Nusser Z, Mody I. Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells. J Neurophysiol 2002;87:2624-8.
30. Jia F, Pignataro L, Schofield CM, Yue M, Harrison NL, Goldstein PA. An extrasynaptic GABAA receptor mediates tonic inhibition in thalamic VB neurons. J Neurophysiol 2005;94:4491-501.
31. Orser BA. Extrasynaptic GABAA receptors are critical targets for sedative-hypnotic drugs. J Clin Sleep Med. 2006;15;2:S12-8.
32. Chen L, Xie JX, Fung KS, Yung WH. Zolpidem modulates GABA(A) receptor function in subthalamic nucleus. Neurosci Res 2007;58:77-85.
33. Najib J. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia. Clin Ther 2006;28:491-516.